Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 50,076 | $810K |
| Grant or award | 2 | 5,118 | |
| Option exercise | 4 | 52,265 | |
| Tax withholding / forfeiture | 2 | 11,366 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Oct 25, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Goff Corinne le - Officer | Open-market sale | Common Stock | 7,032 | $10.25 | $72K | |
| Andrew Enrietti - Officer | Grant or award | Restricted Stock Units | 75,401 | $0.00 | - | |
| Scott Andrew Smith - Officer | Open-market purchase | Common Stock | 22,000 | $9.99 | $220K | |
| David S. Simmons | Grant or award | Restricted Stock Units | 22,820 | $0.00 | - | |
| Frank A. Damelio | Grant or award | Restricted Stock Units | 25,112 | $0.00 | - | |
| Paul Campbell - Officer | Open-market sale | Common Stock | 26,925 | $12.88 | $347K | |
| Harry Korman | Open-market purchase | Common Stock | 613 | $17.15 | $11K | |
| Harry Korman | Open-market purchase | Common Stock | 837 | $16.99 | $14K | |
| Harry Korman | Open-market purchase | Common Stock | 713 | $14.97 | $11K | |
| Harry Korman | Open-market purchase | Common Stock | 349 | $13.94 | $5K | |
| Harry Korman | Open-market purchase | Common Stock | 144.73 | $15.39 | $2K | |
| Harry Korman | Open-market purchase | Common Stock | 162.44 | $13.81 | $2K | |
| Harry Korman | Open-market purchase | Common Stock | 176.17 | $12.84 | $2K | |
| Harry Korman | Open-market purchase | Common Stock | 1,150 | $10.08 | $12K | |
| Harry Korman | Open-market purchase | Common Stock | 238.76 | $10.42 | $2K | |
| Harry Korman | Open-market purchase | Common Stock | 19 | $9.01 | $171 |
This is as far as the anonymous view goes. Create a free account for all 37 VTRS filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Viatris Inc (VTRS) had 4 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for VTRS runs to 37 Form 4 filings, the earliest from 2024-10-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of VTRS were filed in the last 90 days. 13 purchases are on record for this company.
1 insider sale of VTRS was filed in the last 90 days, totaling $810K.
This page tracks VTRS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add VTRS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.